The DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Open accessAbstract
Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related death. Most cases of CRC are detected in Western countries, with its incidence increasing year by year. The probability of suffering from colorectal cancer is about 4%–5% and the risk for developing CRC is associated with personal features or habits such as age, chronic disease history and lifestyle. In this context, the gut microbiota has a relevant role, and dysbiosis situations can induce colonic carcinogenesis through a chronic inflammation mechanism. Some of the bacteria responsible for this multiphase process include Fusobacterium spp, Bacteroides fragilis and enteropathogenic Escherichia coli. CRC is caused by mutations that target oncogenes, tumour suppressor genes and genes related to DNA repair mechanisms. Depending on the origin of the mutation, colorectal carcinomas can be classified as sporadic (70%); inherited (5%) and familial (25%). The pathogenic mechanisms leading to this situation can be included in three types, namely chromosomal instability (CIN), microsatellite instability (MSI) and CpG island methylator phenotype (CIMP). Within these types of CRC, common mutations, chromosomal changes and translocations have been reported to affect important pathways (WNT, MAPK/PI3K, TGF-β, TP53), and mutations; in particular, genes such as c-MYC, KRAS, BRAF, PIK3CA, PTEN, SMAD2 and SMAD4 can be used as predictive markers for patient outcome. In addition to gene mutations, alterations in ncRNAs, such as lncRNA or miRNA, can also contribute to different steps of the carcinogenesis process and have a predictive value when used as biomarkers. In consequence, different panels of genes and mRNA are being developed to improve prognosis and treatment selection. The choice of first-line treatment in CRC follows a multimodal approach based on tumour-related characteristics and usually comprises surgical resection followed by chemotherapy combined with monoclonal antibodies or proteins against vascular endothelial growth factor (VEGF) and epidermal growth receptor (EGFR). Besides traditional chemotherapy, alternative therapies (such as agarose tumour macrobeads, anti-inflammatory drugs, probiotics, and gold-based drugs) are currently being studied to increase treatment effectiveness and reduce side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wan, Y., Li, T., Han, Y., Zhang, H., Lin, H. L., & Zhang, B. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4788 · Cited by 18
RetractedFree radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
Pandey, K. B., & Rizvi, S. I. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9498 · Cited by 3,942
Antioxidant Activity and Total Phenolics in Selected Fruits, Vegetables, and Grain Products
Velioglu, Y. S., Mazza, G., Gao, L., & Oomah, B. D. (1998) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9801973 · Cited by 3,841
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Evolution of mammals and their gut microbes
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., Schlegel, M. L., Tucker, T. A., Schrenzel, M. D., Knight, R., et al. (2008) · Science · doi:10.1126/science.1155725 · Cited by 3,747
Reactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335 · cited 1×
“An increase in cytosolic drug inactivation and a reduction in drug uptake are other possibilities [277,278].”
BackgroundUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Shahidi, F., & Ambigaipalan, P. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.06.018 · Cited by 3,081
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Mattick, J. S., & Makunin, I. V. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl046 · Cited by 2,453
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., & Pandolfi, P. P. (2010) · Nature · doi:10.1038/nature09144 · Cited by 2,323
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., et al. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0018 · Cited by 1,801
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Gut microbiome development along the colorectal adenoma-carcinoma sequence
Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7528 · Cited by 1,506
Morris, K. V., & Mattick, J. S. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3722 · Cited by 1,371
Cunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T., Minsky, B., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,351
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287
Ursell, L. K., Metcalf, J. L., Parfrey, L. W., & Knight, R. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00493.x · Cited by 1,255
Van Cutsem, E., Cervantes, A., Nordlinger, B., & Arnold, D. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu260 · Cited by 1,167
Khambata-Ford, S., Garrett, C. R., Meropol, N. J., Basik, M., Harbison, C. T., Wu, S., Wong, T. W., Huang, X., Takimoto, C. H., Godwin, A. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5437 · Cited by 1,125
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Impacts of gut bacteria on human health and diseases
Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., & Li, H.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047493 · Cited by 1,055 · cited 1×
“For instance, the condition known as dysbiosis, in which the natural relationship between the host and the intestinal microbiota is disrupted [137–140], is considered to be one of the most probable causes of inflammatory bowel disease (IBD) [141–144] or colorectal cancer (CRC) [142,144–147].”
BackgroundPrensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1914 · Cited by 1,029
Fat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
The Chromosomal Instability Pathway in Colon Cancer
Pino, M. S., & Chung, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.065 · Cited by 932
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Smoking and Colorectal Cancer: A Meta-analysis
Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., & Maisonneuve, P. (2008) · JAMA · doi:10.1001/jama.2008.839 · Cited by 778
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., Giovannucci, E. L., & Fuchs, C. S. (2009) · Gut · doi:10.1136/gut.2008.155473 · Cited by 777
Sartore-Bianchi, A., Martini, M., Molinari, F., Veronese, S., Nichelatti, M., Artale, S., Di Nicolantonio, F., Saletti, P., De Dosso, S., Mazzucchelli, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2466 · Cited by 739
Epigenetics and colorectal cancer
Lao, V. V., & Grady, W. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.173 · Cited by 736
PVT1 dependence in cancer with MYC copy-number increase
Tseng, Y.-Y., Moriarity, B. S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., Reuland, B., Guenther, K., Beadnell, T. C., et al. (2014) · Nature · doi:10.1038/nature13311 · Cited by 722
A systematic review and meta-analysis of familial colorectal cancer risk
Johns, L. E., & Houlston, R. S. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04677.x · Cited by 722
Antioxidants in wild mushrooms
Ferreira, I., Barros, L., & Abreu, R. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787909587 · Cited by 670
Ou, J., Carbonero, F., Zoetendal, E. G., DeLany, J. P., Wang, M., Newton, K., Gaskins, H. R., & O’Keefe, S. J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.056689 · Cited by 646
The Gut Microbiome Modulates Colon Tumorigenesis
Zackular, J. P., Baxter, N. T., Iverson, K. D., Sadler, W. D., Petrosino, J. F., Chen, G. Y., & Schloss, P. D. (2013) · mBio · doi:10.1128/mbio.00692-13 · Cited by 629
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
CANAVAN, C., ABRAMS, K. R., & MAYBERRY, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02854.x · Cited by 622
Ling, H., Spizzo, R., Atlasi, Y., Nicoloso, M., Shimizu, M., Redis, R. S., Nishida, N., Gafà, R., Song, J., Guo, Z., et al. (2013) · Genome Research · doi:10.1101/gr.152942.112 · Cited by 602
Cisplatin resistance and opportunities for precision medicine
Amable, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.001 · Cited by 589
lncRNAdb: a reference database for long noncoding RNAs
Amaral, P. P., Clark, M. B., Gascoigne, D. K., Dinger, M. E., & Mattick, J. S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1138 · Cited by 584
miRCancer: a microRNA–cancer association database constructed by text mining on literature
Xie, B., Ding, Q., Han, H., & Wu, D. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt014 · Cited by 572
Diversity of the human gastrointestinal tract microbiota revisited
Rajilić‐Stojanović, M., Smidt, H., & De Vos, W. M. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01369.x · Cited by 559
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209009 · Cited by 552
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Salazar, R., Roepman, P., Capella, G., Moreno, V., Simon, I., Dreezen, C., Lopez-Doriga, A., Santos, C., Marijnen, C., Westerga, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1077 · Cited by 537
Development of intestinal microbiota in infants and its impact on health
Matamoros, S., Gras-Leguen, C., Le Vacon, F., Potel, G., & de La Cochetiere, M.-F. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2012.12.001 · Cited by 534
lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs
Quek, X. C., Thomson, D. W., Maag, J. L. V., Bartonicek, N., Signal, B., Clark, M. B., Gloss, B. S., & Dinger, M. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku988 · Cited by 527
Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis
Liang, P. S., Chen, T., & Giovannucci, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24191 · Cited by 524
Fusobacterium Is Associated with Colorectal Adenomas
McCoy, A. N., Araújo-Pérez, F., Azcárate-Peril, A., Yeh, J. J., Sandler, R. S., & Keku, T. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053653 · Cited by 515
Metal-based anticancer chemotherapeutic agents
Muhammad, N., & Guo, Z. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.02.003 · Cited by 515
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M. A., Mitchell, E., Miller, M. C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn786 · Cited by 513
Reciprocal Regulation of HIF-1α and LincRNA-p21 Modulates the Warburg Effect
Yang, F., Zhang, H., Mei, Y., & Wu, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.11.004 · Cited by 510
Auranofin: Repurposing an Old Drug for a Golden New Age
Roder, C., & Thomson, M. J. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0083-y · Cited by 497
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
Van Cutsem, E., Nordlinger, B., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq222 · Cited by 479
Yang, F., Huo, X.-S., Yuan, S.-X., Zhang, L., Zhou, W.-P., Wang, F., & Sun, S.-H. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.010 · Cited by 477
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Karasawa, T., & Steyger, P. S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.012 · Cited by 475
Colonization of the Human Gut by E. coli and Colorectal Cancer Risk
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D., & Darfeuille-Michaud, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1343 · Cited by 475
Brody, H. (2015) · Nature · doi:10.1038/521s1a · Cited by 475
Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A., Whitmore, A. C., Hillhouse, A., Curry, K. P., Renner, S. W., Greenwalt, A., Ryan, E. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0501 · Cited by 474
A vegan or vegetarian diet substantially alters the human colonic faecal microbiota
Zimmer, J., Lange, B., Frick, J.-S., Sauer, H., Zimmermann, K., Schwiertz, A., Rusch, K., Klosterhalfen, S., & Enck, P. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.141 · Cited by 465 · cited 1×
“Many factors, such as antibiotic treatment or some types of diet, are known to be involved in the development of dysbiosis [139,148,149].”
BackgroundGene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer
Wang, Y., Jatkoe, T., Zhang, Y., Mutch, M. G., Talantov, D., Jiang, J., McLeod, H. L., & Atkins, D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.186 · Cited by 460
Dietary effects on human gut microbiome diversity
Xu, Z., & Knight, R. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004127 · Cited by 456
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
Tsang, W. P., Ng, E. K. O., Ng, S. S. M., Jin, H., Yu, J., Sung, J. J. Y., & Kwok, T. T. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp181 · Cited by 456
Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Chen, Y., Yang, F., Lu, N., Wang, Z., et al. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0245-9 · Cited by 454
Processed Meat and Colorectal Cancer: A Review of Epidemiologic and Experimental Evidence
Santarelli, R., Pierre, F., & Corpet, D. (2008) · Nutrition and Cancer · doi:10.1080/01635580701684872 · Cited by 446
Poschl, G. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh057 · Cited by 442
The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota
Engen, P. (2015) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v37.2.07 · Cited by 436
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
Zhang, X., Zhou, Y., Mehta, K. R., Danila, D. C., Scolavino, S., Johnson, S. R., & Klibanski, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030222 · Cited by 435
Marzano, C., Gandin, V., Folda, A., Scutari, G., Bindoli, A., & Rigobello, M. P. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.021 · Cited by 415
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Bastide, N. M., Pierre, F. H. F., & Corpet, D. E. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0113 · Cited by 397 · cited 1×
“For instance, red meat releases heme groups in the intestine, which enhance the formation of carcinogenic N-nitroso compounds as well as cytotoxic and genotoxic aldehydes by lipoperoxidation [20], and meat cooked at high temperatures produces heterocyclic amines and polycyclic hydrocarbons after digestion, both of whi…”
BackgroundBacterial biogeography of the human digestive tract
Stearns, J. C., Lynch, M. D. J., Senadheera, D. B., Tenenbaum, H. C., Goldberg, M. B., Cvitkovitch, D. G., Croitoru, K., Moreno-Hagelsieb, G., & Neufeld, J. D. (2011) · Scientific Reports · doi:10.1038/srep00170 · Cited by 397
LncRNA loc285194 is a p53-regulated tumor suppressor
Liu, Q., Huang, J., Zhou, N., Zhang, Z., Zhang, A., Lu, Z., Wu, F., & Mo, Y.-Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt182 · Cited by 384
Cancer Biomarkers: Can We Turn Recent Failures into Success?
Diamandis, E. P. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq306 · Cited by 376
Haptoglobin, inflammation and disease
Quaye, I. K. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.04.010 · Cited by 371
Jacobs, B., De Roock, W., Piessevaux, H., Van Oirbeek, R., Biesmans, B., De Schutter, J., Fieuws, S., Vandesompele, J., Peeters, M., Van Laethem, J.-L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3744 · Cited by 368
Kim, Y.-G., Udayanga, K. G. S., Totsuka, N., Weinberg, J. B., Núñez, G., & Shibuya, A. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.010 · Cited by 366
A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate
Fung, K. Y. C., Cosgrove, L., Lockett, T., Head, R., & Topping, D. L. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001948 · Cited by 360
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Link, A., Balaguer, F., Shen, Y., Nagasaka, T., Lozano, J. J., Boland, C. R., & Goel, A. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0027 · Cited by 354
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis
Sears, C. L., Geis, A. L., & Housseau, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72334 · Cited by 353
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Nosho, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.557 · Cited by 344
Wang, F., Li, X., Xie, X., Zhao, L., & Chen, W. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.012 · Cited by 339
Umetani, N., Kim, J., Hiramatsu, S., Reber, H. A., Hines, O. J., Bilchik, A. J., & Hoon, D. S. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068577 · Cited by 331
Bertucci, F., Salas, S., Eysteries, S., Nasser, V., Finetti, P., Ginestier, C., Charafe-Jauffret, E., Loriod, B., Bachelart, L., Montfort, J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207262 · Cited by 326
Li, Z. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1007 · Cited by 323
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.008 · Cited by 322 · cited 1×
“Despite their anti-inflammatory properties, NSAIDs have negative side effects such as gastrointestinal ulcerations or kidney damage [234], hence they are mostly used to prevent CRC in high-risk patients, such as those with Crohn’s disease, ulcerative colitis or FAP, rather than for treatment.”
BackgroundThe human gut microbiota and virome: Potential therapeutic implications
Scarpellini, E., Ianiro, G., Attili, F., Bassanelli, C., De Santis, A., & Gasbarrini, A. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.07.008 · Cited by 315
Seasonal Variation in Human Gut Microbiome Composition
Davenport, E. R., Mizrahi-Man, O., Michelini, K., Barreiro, L. B., Ober, C., & Gilad, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090731 · Cited by 314
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Mahmood, D. F. D., Abderrazak, A., El Hadri, K., Simmet, T., & Rouis, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4757 · Cited by 305
Cancer-promoting effects of microbial dysbiosis
Sheflin, A. M., Whitney, A. K., & Weir, T. L. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0406-0 · Cited by 301
Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells.
Wenzel, U., Kuntz, S., Brendel, M. D., & Daniel, H. (2000) · PubMed · Cited by 295
Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro
Choi, S. S., Kim, Y., Han, K. S., You, S., Oh, S., & Kim, S. H. (2006) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2006.01913.x · Cited by 292
P53 abnormalities and outcomes in colorectal cancer: a systematic review
Munro, A. J., Lain, S., & Lane, D. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602358 · Cited by 289
Goldstein, J., Tran, B., Ensor, J., Gibbs, P., Wong, H. L., Wong, S. F., Vilar, E., Tie, J., Broaddus, R., Kopetz, S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu100 · Cited by 288
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
Takahashi, Y., Sawada, G., Kurashige, J., Uchi, R., Matsumura, T., Ueo, H., Takano, Y., Eguchi, H., Sudo, T., Sugimachi, K., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.698 · Cited by 287
(2016) · PubMed · Cited by 287
Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility
Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01737.x · Cited by 286
Extraction of Polyphenolics from Plant Material for Functional Foods—Engineering and Technology
Shi, J., Nawaz, H., Pohorly, J., Mittal, G., Kakuda, Y., & Jiang, Y. (2005) · Food Reviews International · doi:10.1081/fri-200040606 · Cited by 281
Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
Migliore, L., Migheli, F., Spisni, R., & Coppedè, F. (2011) · BioMed Research International · doi:10.1155/2011/792362 · Cited by 278
Yaeger, R., Cercek, A., O'Reilly, E. M., Reidy, D. L., Kemeny, N., Wolinsky, T., Capanu, M., Gollub, M. J., Rosen, N., Berger, M. F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2779 · Cited by 276
Aspirin use, cancer, and polyps of the large bowel
Suh, O., Mettlin, C., & Petrelli, N. J. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d · Cited by 276
Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
Bacher, J. W., Flanagan, L. A., Smalley, R. L., Nassif, N. A., Burgart, L. J., Halberg, R. B., Megid, W. M. A., & Thibodeau, S. N. (2004) · Disease Markers · doi:10.1155/2004/136734 · Cited by 276
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
Fransen, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh049 · Cited by 268
Acute nephrotoxicity of cisplatin: Molecular mechanisms
Peres, L. A. B., & Cunha Júnior, A. D. D. (2013) · Jornal Brasileiro de Nefrologia · doi:10.5935/0101-2800.20130052 · Cited by 261
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Liao, X., Morikawa, T., Lochhead, P., Imamura, Y., Kuchiba, A., Yamauchi, M., Nosho, K., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2410 · Cited by 258
Yang, F., Xue, X., Bi, J., Zheng, L., Zhi, K., Gu, Y., & Fang, G. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1324-x · Cited by 256
Emerging roles of lactic acid bacteria in protection against colorectal cancer
Zhong, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7878 · Cited by 256
Graham, L. D., Pedersen, S. K., Brown, G. S., Ho, T., Kassir, Z., Moynihan, A. T., Vizgoft, E. K., Dunne, R., Pimlott, L., Young, G. P., et al. (2011) · Genes & Cancer · doi:10.1177/1947601911431081 · Cited by 256
PCAT-1 , a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer
Prensner, J. R., Chen, W., Iyer, M. K., Cao, Q., Ma, T., Han, S., Sahu, A., Malik, R., Wilder-Romans, K., Navone, N., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3159 · Cited by 251
Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.
Nie, L., Wu, H., Hsu, J.-M., Chang, S.-S., LaBaff, A. M., Li, C. W., Wang, Y., Hsu, J. L., & Hung, M. (2012) · Europe PMC (PubMed Central) · Cited by 250
Dysbiotic Events in Gut Microbiota: Impact on Human Health
Schippa, S., & Conte, M. (2014) · Nutrients · doi:10.3390/nu6125786 · Cited by 246
Structural and Functional Differences in the Long Non-Coding RNA Hotair in Mouse and Human
Schorderet, P., & Duboule, D. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002071 · Cited by 236
The interplay between the gut microbiota and the immune system
Geuking, M. B., Köller, Y., Rupp, S., & McCoy, K. D. (2014) · Gut Microbes · doi:10.4161/gmic.29330 · Cited by 228
Mercury in Traditional Medicines: Is Cinnabar Toxicologically Similar to Common Mercurials?
Liu, J., Shi, J.-Z., Yu, L.-M., Goyer, R. A., & Waalkes, M. P. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-336 · Cited by 224
Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells
Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., Marian, B., Lichtenberg, D., & Arber, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0171 · Cited by 221
Sah, B. N. P., Vasiljevic, T., McKechnie, S., & Donkor, O. N. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.01.105 · Cited by 216
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Sastre, J., Maestro, M. L., Puente, J., Veganzones, S., Alfonso, R., Rafael, S., García-Saenz, J. A., Vidaurreta, M., Martín, M., Arroyo, M., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm583 · Cited by 215
Recent Therapeutic Advances in the Treatment of Colorectal Cancer
Ciombor, K. K., Wu, C., & Goldberg, R. M. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051513-102539 · Cited by 215
Stage II Colon Cancer Prognosis Prediction by Tumor Gene Expression Profiling
Barrier, A., Boelle, P.-Y., Roser, F., Gregg, J., Tse, C., Brault, D., Lacaine, F., Houry, S., Huguier, M., Franc, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0229 · Cited by 214
Pathways and functions of gut microbiota metabolism impacting host physiology
Krishnan, S., Alden, N., & Lee, K. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.08.015 · Cited by 212
Colorectal Cancer Biomarkers: Where Are We Now?
Gonzalez-Pons, M., & Cruz-Correa, M. (2015) · BioMed Research International · doi:10.1155/2015/149014 · Cited by 209
Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review
Hundt, S., Haug, U., & Brenner, H. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0994 · Cited by 209
Microbiota-stimulated immune mechanisms to maintain gut homeostasis
Chung, H., & Kasper, D. L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.008 · Cited by 205
Analysis of the intricate relationship between chronic inflammation and cancer
Chai, E. Z. P., Siveen, K. S., Shanmugam, M. K., Arfuso, F., & Sethi, G. (2015) · Biochemical Journal · doi:10.1042/bj20141337 · Cited by 202
Inflammation and colorectal cancer, when microbiota-host mutualism breaks
Candela, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.908 · Cited by 197
Effects of Long-term Sulindac Therapy on Colonic Polyposis
Rigau, J., Piqué, J. M., Rubio, E., Planas, R., Tarrech, J. M., & Bordas, J. M. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-952 · Cited by 196
Role of colonic microbiota in colorectal carcinogenesis: A systematic review
Borges Canha, M. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3830/2015 · Cited by 193
Pala, V., Sieri, S., Berrino, F., Vineis, P., Sacerdote, C., Palli, D., Masala, G., Panico, S., Mattiello, A., Tumino, R., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26193 · Cited by 190
Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis
Matouk, I. J., Abbasi, I., Hochberg, A., Galun, E., Dweik, H., & Akkawi, M. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328306a3a2 · Cited by 190
Ge, X., Chen, Y., Liao, X., Liu, D., Li, F., Ruan, H., & Jia, W. (2013) · Medical Oncology · doi:10.1007/s12032-013-0588-6 · Cited by 190
Kennedy, R. D., Bylesjo, M., Kerr, P., Davison, T., Black, J. M., Kay, E. W., Holt, R. J., Proutski, V., Ahdesmaki, M., Farztdinov, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.4498 · Cited by 190
Red meat and colorectal cancer
Aykan, N. F. (2015) · Oncology Reviews · doi:10.4081/oncol.2015.288 · Cited by 188
Popat, S., & Houlston, R. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.039 · Cited by 187
Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5
Kim, T., Cui, R., Jeon, Y.-J., Lee, J.-H., Lee, J. H., Sim, H., Park, J. K., Fadda, P., Tili, E., Nakanishi, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400350111 · Cited by 186
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients
Li, Y.-Y., Ge, Q.-X., Cao, J., Zhou, Y.-J., Du, Y.-L., Shen, B., Wan, Y.-J. Y., & Nie, Y.-Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3227 · Cited by 175
From cultured to uncultured genome sequences: metagenomics and modeling microbial ecosystems
Garza, D. R., & Dutilh, B. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2004-1 · Cited by 175
Yothers, G., O'Connell, M. J., Lee, M., Lopatin, M., Clark-Langone, K. M., Millward, C., Paik, S., Sharif, S., Shak, S., & Wolmark, N. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3116 · Cited by 173
Pathogenic role of the gut microbiota in gastrointestinal diseases
Nagao-Kitamoto, H., Kitamoto, S., Kuffa, P., & Kamada, N. (2016) · Intestinal Research · doi:10.5217/ir.2016.14.2.127 · Cited by 172
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
The role of microRNAs in colorectal cancer
Liu, M., & Chen, H. (2010) · Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60053-9 · Cited by 166
Review of the association between meat consumption and risk of colorectal cancer
Kim, E., Coelho, D., & Blachier, F. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.07.018 · Cited by 164
Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer
Rennoll, S. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.290 · Cited by 162
Sequencing the human microbiome in health and disease
Cox, M. J., Cookson, W. O. C. M., & Moffatt, M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt398 · Cited by 160
The human gut microbiome, a taxonomic conundrum
Sankar, S. A., Lagier, J., Pontarotti, P., Raoult, D., & Fournier, P. (2015) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2015.03.004 · Cited by 157
Recognition and repair of DNA-cisplatin adducts.
Woźniak, K., & Błasiak, J. (2002) · Acta Biochimica Polonica · doi:10.18388/abp.2002_3768 · Cited by 155
Chong, E. S. L. (2013) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1499-6 · Cited by 155
A blood‐based biomarker panel for stratifying current risk for colorectal cancer
Marshall, K., Mohr, S., Khettabi, F. E., Nossova, N., Chao, S. T., Bao, W., Ma, J., Li, X., & Liew, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24910 · Cited by 154
Rosty, C., Young, J. P., Walsh, M. D., Clendenning, M., Sanderson, K., Walters, R., Parry, S., Jenkins, M. A., Win, A. K., Southey, M. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065479 · Cited by 153
The Role of Inflammation in Colon Cancer
Janakiram, N. B., & Rao, C. V. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_2 · Cited by 151
Microsatellite Instability and Colorectal Cancer
Geiersbach, K. B., & Samowitz, W. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0035-ra · Cited by 151
Critical Evaluation of Current Treatments in Metastatic Colorectal Cancer
Venook, A. P. (2005) · The Oncologist · doi:10.1634/theoncologist.10-4-250 · Cited by 151
Ahmed, F., Ahmed, N. C., Vos, P. W., Bonnerup, C., Atkins, J. N., Casey, M., Nuovo, G. J., Naziri, W., Wiley, J. E., Mota, H., et al. (2013) · PubMed · Cited by 150
Chen, C., Lin, W.-C., Kong, M., Shi, H. N., Walker, W. A., Lin, C., Huang, C.-T., Lin, Y., Jung, S.-M., & Lin, T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004934 · Cited by 150
Transition Metal Based Anticancer Drugs
Garbutcheon‐Singh, K. B., Grant, M. P., Harper, B. W. J., Krause‐Heuer, A. M., Manohar, M., Orkey, N., & Aldrich-Wright, J. R. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794785226 · Cited by 150
Liu, X., Zhang, Z., Sun, L. J., Chai, N., Tang, S., Jin, J., Hu, H., Nie, Y., Wang, X., Wu, K., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr213 · Cited by 150
Morkel, M., Riemer, P., Bläker, H., & Sers, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4750 · Cited by 147
Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer
Han, H., Gu, J., Zuo, H., Chen, Z., Zhao, W., Li, M., Ji, D., Lu, Y., & Zhang, Z. (2011) · The Journal of Pathology · doi:10.1002/path.3014 · Cited by 147
Diet and Cancer: An Evolving Picture
Willett, W. C. (2005) · JAMA · doi:10.1001/jama.293.2.233 · Cited by 146
Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives
Kahouli, I., Tomaro-Duchesneau, C., & Prakash, S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.048975-0 · Cited by 145
Third row transition metals for the treatment of cancer
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2015) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2014.0185 · Cited by 143
Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut
Bashir, A., Miskeen, A. Y., Hazari, Y., Asrafuzzaman, S., & Fazili, K. M. (2015) · Tumor Biology · doi:10.1007/s13277-015-4724-0 · Cited by 139
The inhibition of tumor growth by tumor mass.
Prehn, R. T. (1991) · PubMed · Cited by 138
Fusobacterium and Enterobacteriaceae: Important players for CRC?
Allen‐Vercoe, E., & Jobin, C. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.05.014 · Cited by 137
Sobhani, I., Amiot, A., Baleur, Y. L., Levy, M. L., Auriault, M., Nhieu, J. T. V., & Delchier, J. C. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12473674 · Cited by 133
Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes
Tomasello, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18121 · Cited by 126
Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells
Buac, D., Schmitt, S. M., Ventro, G. J., Kona, F. R., & Dou, Q. P. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712802762040 · Cited by 125
Maak, M., Simón, I., Nitsche, U., Roepman, P., Snel, M. H. J., Glas, A. M., Schuster, T., Keller, G., Zeestraten, E. C. M., Goossens, I., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827c1180 · Cited by 120
Building the microbiome in health and disease: niche construction and social conflict in bacteria
McNally, L., & Brown, S. P. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0298 · Cited by 118
Wheeler, J., Loukola, A., Aaltonen, L. A., Mortensen, N. J. M., & Bodmer, W. F. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.8.588 · Cited by 116
Baker, J. B., Dutta, D., Watson, D., Maddala, T., Munneke, B., Shak, S., Rowinsky, E. K., Xu, L.-A., Harbison, C. T., Clark, E. A., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606054 · Cited by 111
Zhang, X., Frezza, M., Milacic, V., Ronconi, L., Fan, Y., Bi, C., Fregona, D., & Dou, Q. P. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22394 · Cited by 111
Rosa canina Extracts Have Antiproliferative and Antioxidant Effects on Caco-2 Human Colon Cancer
Jiménez, S., Gascón, S., Luquín, A., Laguna, M., Ancín‐Azpilicueta, C., & Rodriguez‐Yoldi, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159136 · Cited by 110
Self-citationExpression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers
Nakano, S., Murakami, K., Meguro, M., Soejima, H., Higashimoto, K., Urano, T., Kugoh, H., Mukai, T., Ikeguchi, M., & Oshimura, M. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00305.x · Cited by 106
Tang, J. T., Wang, J., Du, W., Hong, J., Zhao, S., Wang, Y., Xiong, H., Chen, H., & Fang, J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr114 · Cited by 105
Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers
Miller, A. C., Rashid, R. M., Falzon, L., Elamin, E. M., & Zehtabchi, S. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.014 · Cited by 102
Cloning of the mRNA of overexpression in colon carcinoma-1
Pibouin-Fragner, L., Villaudy, J., Ferbus, D., Muleris, M., Prosperi, M., Remvikos, Y., & Goubin, G. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00634-3 · Cited by 99
Cited by
Hibberd, A. A., Lyra, A., Ouwehand, A. C., Rolny, P., Lindegren, H., Cedgård, L., & Wettergren, Y. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000145 · Cited by 373
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
Yaghoubi, N., Soltani, A., Ghazvini, K., Hassanian, S. M., & Hashemy, S. I. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.105 · Cited by 299
Deng, X., Li, Z., Li, G., Li, B., Jin, X., & Lyu, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01607 · Cited by 114
Alvandi, E., Wong, W. K. M., Joglekar, M. V., Spring, K. J., & Hardikar, A. A. (2022) · BMC Medicine · doi:10.1186/s12916-022-02529-4 · Cited by 101
IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
Cui, J., Tian, J., Wang, W., He, T., Li, X., Gu, C., Wang, L., Wu, J., & Shang, A. (2021) · Cancer Science · doi:10.1111/cas.15083 · Cited by 90
Metadata
- Authors
- Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-01-19
- Volume
- 18
- Issue
- 1
- Pages
- 197
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2579357550
- Cited by
- 1,525
- References
- 267
- FWCI
- 58.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.